Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amylyx Pharmaceuticals (AMLX) Inventory (2022 - 2023)

Historic Inventory for Amylyx Pharmaceuticals (AMLX) over the last 2 years, with Q4 2023 value amounting to $38.3 million.

  • Amylyx Pharmaceuticals' Inventory rose 29229.19% to $38.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $38.3 million, marking a year-over-year increase of 29229.19%. This contributed to the annual value of $38.3 million for FY2023, which is 29229.19% up from last year.
  • As of Q4 2023, Amylyx Pharmaceuticals' Inventory stood at $38.3 million, which was up 29229.19% from $32.4 million recorded in Q3 2023.
  • In the past 5 years, Amylyx Pharmaceuticals' Inventory ranged from a high of $38.3 million in Q4 2023 and a low of $563000.0 during Q3 2022